These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17545775)

  • 1. Biological therapies in inflammatory bowel disease: top-down or bottom-up?
    Oldenburg B; Hommes D
    Curr Opin Gastroenterol; 2007 Jul; 23(4):395-9. PubMed ID: 17545775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are we ready for top-down therapy for inflammatory bowel diseases: con.
    Herfarth H
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):249-55. PubMed ID: 19072417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical therapy for Crohn's disease: top-down or step-up?
    Baert F; Caprilli R; Angelucci E
    Dig Dis; 2007; 25(3):260-6. PubMed ID: 17827952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the optimal therapy for Crohn's disease: step-up or top-down?
    Lin MV; Blonski W; Lichtenstein GR
    Expert Rev Gastroenterol Hepatol; 2010 Apr; 4(2):167-80. PubMed ID: 20350264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppression in inflammatory bowel disease: traditional, biological or both?
    Van Assche G; Vermeire S; Rutgeerts P
    Curr Opin Gastroenterol; 2009 Jul; 25(4):323-8. PubMed ID: 19417645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory bowel disease therapy: current state-of-the-art.
    Blonski W; Buchner AM; Lichtenstein GR
    Curr Opin Gastroenterol; 2011 Jul; 27(4):346-57. PubMed ID: 21654383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab in Crohn's disease: early and long-term treatment.
    Armuzzi A; De Pascalis B; Fedeli P; De Vincentis F; Gasbarrini A
    Dig Liver Dis; 2008 Jul; 40 Suppl 2():S271-9. PubMed ID: 18599000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Top-down versus Step-Up: new strategies in the treatment of Crohn's disease].
    Meier J; Sturm A
    Z Gastroenterol; 2009 Feb; 47(2):240-2. PubMed ID: 19197829
    [No Abstract]   [Full Text] [Related]  

  • 9. Infliximab use in children and adolescents with inflammatory bowel disease.
    de Ridder L; Benninga MA; Taminiau JA; Hommes DW; van Deventer SJ
    J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):3-14. PubMed ID: 17592358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State-of-the-art: Immunosuppression and biologic therapy.
    Sandborn WJ
    Dig Dis; 2010; 28(3):536-42. PubMed ID: 20926883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of chronic inflammatory bowel diseases].
    Lémann M
    Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical treatment of inflammatory bowel diseases.
    Van Assche G; Vermeire S; Rutgeerts P
    Curr Opin Gastroenterol; 2005 Jul; 21(4):443-7. PubMed ID: 15930985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab therapy in children with Crohn's disease: a one-year evaluation of efficacy comparing 'top-down' and 'step-up' strategies.
    Kim MJ; Lee JS; Lee JH; Kim JY; Choe YH
    Acta Paediatr; 2011 Mar; 100(3):451-5. PubMed ID: 20626362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab therapy for patients with inflammatory bowel disease: 10 years on.
    Van Assche G; Vermeire S; Rutgeerts P
    Eur J Pharmacol; 2009 Nov; 623 Suppl 1():S17-25. PubMed ID: 19837056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical perspectives in Crohn's disease. Turning traditional treatment strategies on their heads: current evidence for "step-up" versus "top-down".
    Hanauer SB
    Rev Gastroenterol Disord; 2007; 7 Suppl 2():S17-22. PubMed ID: 17392635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic approaches in inflammatory bowel disease based on the immunopathogenesis.
    Siegmund B; Zeitz M
    Rocz Akad Med Bialymst; 2004; 49():22-30. PubMed ID: 15631310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: Altering the natural history of Crohn's disease--evidence for and against current therapies.
    Vermeire S; van Assche G; Rutgeerts P
    Aliment Pharmacol Ther; 2007 Jan; 25(1):3-12. PubMed ID: 17229216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance of medically induced remission of Crohn's disease.
    Gonvers JJ; Juillerat P; Mottet C; Pittet V; Felley C; Vader JP; Michetti P; Froehlich F
    Digestion; 2007; 76(2):116-29. PubMed ID: 18239403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?
    Rutgeerts P; Vermeire S; Van Assche G
    Gut; 2007 Apr; 56(4):453-5. PubMed ID: 17369375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: remission rates achievable by current therapies for inflammatory bowel disease.
    Peyrin-Biroulet L; Lémann M
    Aliment Pharmacol Ther; 2011 Apr; 33(8):870-9. PubMed ID: 21323689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.